Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.

@article{Sinescu2011LongtermEO,
  title={Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.},
  author={Ioanel Sinescu and Petrişor Aurelian Geavlete and Răzvan Mulţescu and Constantin Gangu and F. Miclea and Ioan Mircea Coman and Ioan Ioiart and Valentin Ambert and Traian Constantin and Bogdan Petrut and Bogdan Feciche},
  journal={Urologia internationalis},
  year={2011},
  volume={86 3},
  pages={
          284-9
        }
}
INTRODUCTION The study aimed to evaluate the long-term efficacy of treatment with extract of Serenoa repens (Prostamol Uno) in patients with lower urinary tract symptoms (LUTS) induced by benign prostatic hyperplasia (BPH). PATIENTS AND METHODS We studied 120 patients with mild or moderate LUTS induced by BPH, maximal urinary flow (Q(max)) <15 ml with a voided volume ≥150 ml, prostate-specific antigen <4 ng/ml, and residual urinary volume <150 ml, treated daily for 24 months with one capsule… CONTINUE READING
Tweets
This paper has been referenced on Twitter 3 times. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

A prospective study of the efficacy of Serenoa repens , tamsulosin , and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia

  • F Hizli, MC Uygur
  • Int Urol Nephrol
  • 2007

First results of a clinical trial of the efficacy and safety of Prostamol  Uno in patients with the early signs of prostatic hyperplasia

  • YG Alyaev, OI Apolikhin, +5 authors ME Shkol’nikov
  • Eff Phar - macother Urol
  • 2007

Uygur MC: A prospective study of the efficacy of Serenoa repens

  • F Hizli
  • Int Urol Nephrol
  • 2007

Similar Papers

Loading similar papers…